跳至主要内容
临床试验/EUCTR2011-002219-28-IT
EUCTR2011-002219-28-IT进行中(未招募)不适用

Effect of pharmacological prophylaxis with low molecular weight heparin on implantation in women undergoing assisted reproductive procedures to prevent implant failure: a prospective randomized study.

AZIENDA OSPEDALIERA DI PADOVA0 个研究点开始时间: 2012年3月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • age >18 • presence of one of the following risk factors: thrombophilia (Factor V Leiden, PG20210A mutation, MTHFR C677T gene mutation), 2 or more previous implantation failures •Informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 600
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria; • age < 18; • deficiency of antitrombin, protein C, protein S, antiphospholipid antibodies, previous VTE • no informed consent.

研究者

发起方
AZIENDA OSPEDALIERA DI PADOVA

相似试验